.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
McKesson
Covington
US Department of Justice
Harvard Business School
Medtronic
Deloitte
Julphar
Accenture
Fuji

Generated: June 28, 2017

DrugPatentWatch Database Preview

TOBRAMYCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Tobramycin, and what generic Tobramycin alternatives are available?

Tobramycin is a drug marketed by Amneal Pharms, Akorn Inc, Fera Pharms, Bausch And Lomb, Lupin Atlantis, Alcon Pharms Ltd, Apotex Inc, Teva Pharms Usa, Mylan Labs Ltd, Hospira, West-ward Pharms Int, X Gen Pharms, Igi Labs Inc, Apothecon, Fresenius Kabi Usa, Watson Labs Inc, Claris, Akorn, and Xellia Pharms Aps. and is included in thirty-six NDAs.

The generic ingredient in TOBRAMYCIN is tobramycin sulfate. There are eighteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the tobramycin sulfate profile page.

Summary for Tradename: TOBRAMYCIN

Patents:0
Applicants:19
NDAs:36
Suppliers / Packagers: see list14
Bulk Api Vendors: see list43
Clinical Trials: see list90
Patent Applications: see list6,619
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TOBRAMYCIN at DailyMed

Pharmacology for Tradename: TOBRAMYCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
TOBRAMYCIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
tobramycin sulfate
INJECTABLE;INJECTION063081-001Jul 31, 1990RXNoYes► Subscribe► Subscribe
Claris
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION206965-001Jul 1, 2016APRXNoNo► Subscribe► Subscribe
West-ward Pharms Int
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION063128-001Nov 27, 1991DISCNNoNo► Subscribe► Subscribe
Akorn
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION205179-001Sep 16, 2014APRXNoNo► Subscribe► Subscribe
Watson Labs Inc
TOBRAMYCIN SULFATE
tobramycin sulfate
INJECTABLE;INJECTION062945-001Aug 9, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Farmers Insurance
Chubb
Novartis
Daiichi Sankyo
Johnson and Johnson
Healthtrust
QuintilesIMS
Boehringer Ingelheim
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot